Monoferric for Prenatal Iron Deficiency
Oregon Health and Science University · NCT05763043
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- January 18, 2024
- Record last updated
- September 19, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.
Being studied: Ferric derisomaltose
Conditions: Obstetric Labor Complications
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Participants 18 years of age or older between 14 to 42 weeks gestation who are deemed appropriate for IV iron by their treating provider as part of their standard of care treatment.
- Iron deficiency anemia, defined as second or third trimester (14 weeks or more) hemoglobin less than or equal to 10.5 g/dL or less than or equal to11 g/dL, respectively, and ferritin less than 50 μg/L
- Experience intolerance to oral iron or are greater than 28 weeks gestation
- Willing to participate in the study
Exclusion Criteria
- Known infectious, inflammatory, or malignant conditions that may confound iron repletion and outcome analysis
- Prior IV iron intolerance or hypersensitivity reaction
Recruiting US locations
Oregon Health & Science Univerity
Portland, OR 97239
Site contact: Women's Health Research Unit · 503-494-3666 · whru@ohsu.edu
Study contacts (from the official record)
- Women's Health Research Unit Research Unit Department of OB/Gyn · 503-494-3666 · whru@ohsu.edu
Similar studies in Oregon
All pregnancy studies in Oregon →- RecruitingPhase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC
- Location
- Portland, OR + 19 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Janssen Research & Development, LLC
- Location
- Portland, OR + 11 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteers
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Yale University
- Location
- Portland, OR + 32 other US sites
- Eligibility basics
- Ages 15–55 · Women only
- RecruitingHealthy volunteers
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
Jaeb Center for Health Research
- Location
- Portland, OR + 7 other US sites
- Eligibility basics
- Ages 18+ · Women only